Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 139

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 139
---
 shares issued pursuant to the February 2024 Keystone Purchase Agreement shall not exceed 12,500 shares (the “Initial Limit”). In accordance with our obligations under the February 2024 Keystone Purchase Agreement and the February 2024 Keystone Registration Rights Agreement, we previously filed a registration statement on S-1 (File No. 333-278603) in order to register the resale of up to: (i) 12,500 Keystone Purchase Shares that we may elect, in our sole discretion, to issue and sell to Keystone, from time to time from and after the Keystone Commencement Date upon the terms and subject to the conditions and limitations of the February 2024 Keystone Purchase Agreement, subject to applicable stock exchange rules (assuming the shares are sold at a price of $2,000.00 per share) and (ii) 310 Keystone Commitment Shares that have been issued to Keystone as consideration for its execution and delivery of the February 2024 Keystone Purchase Agreement (assuming the shares to be issued are sold at a price of $2,000.00 per share). In November 2024, in order to enable us to issue and sell additional shares in excess of the Initial Limit and up to $25,000,000, we entered into the November 2024 Keystone Purchase Agreement with Keystone, pursuant to which we may issue and sell up to $20,589,384 of shares of Common Stock. 74 In accordance with our obligations under the November 2024 Keystone Purchase Agreement and the November 2024 Keystone Registration Rights Agreement, we previously filed a registration statement on S-1 (File No. 333-283492) in order to register the resale of up to: (i) 104,318 Keystone Purchase Shares that we may elect, in our sole discretion, to issue and sell to Keystone, from time to time from and after the Keystone Commencement Date upon the terms and subject to the conditions and limitations of the November 4 Keystone Purchase Agreement and (ii) 682 Keystone Commitment Shares that have been issued to Keystone as consideration for its establishing the Keystone Equity Financing. On July 11, 2025, we entered into the New Keystone Purchase Agreement with Keystone, pursuant to which we may issue and sell up to 12,500,000 shares of Common Stock that we may elect, in our sole discretion, from time to time from and after the Keystone Commencement Date. The shares of our Common Stock that may be issued under the Keystone Purchase Agreements may be